Kevin M. Thewlis

1.1k citations

18 papers · 485 indexed · h-index 12

Co-authors: Geoffrey Stemp Martyn Wood Philip D. Jeffrey Nigel Austin Graham J. Riley Antonio Vong Michael S. Hadley Frank E. Blaney
Topics: Receptor Mechanisms and Signaling (13 papers)Neurotransmitter Receptor Influence on Behavior (7 papers)Pharmacological Receptor Mechanisms and Effects (6 papers)
Cited by: Cellular and Molecular Neuroscience Molecular Biology Pharmaceutical Science
Journals: Journal of Medicinal Chemistry Bioorganic & Medicinal Chemistry Bioorganic & Medicinal Chemistry Letters
Partner nations: United Kingdom United States Canada

In The Last Decade

Kevin M. Thewlis

18 papers receiving 452 citations

Peers

Countries citing papers authored by Kevin M. Thewlis

Since Specialization

Citations

This map shows the geographic impact of Kevin M. Thewlis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin M. Thewlis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin M. Thewlis more than expected).

Fields of papers citing papers by Kevin M. Thewlis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin M. Thewlis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin M. Thewlis. The network helps show where Kevin M. Thewlis may publish in the future.

Co-authorship network of co-authors of Kevin M. Thewlis

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin M. Thewlis. A scholar is included among the top collaborators of Kevin M. Thewlis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin M. Thewlis. Kevin M. Thewlis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	N-Substituted pyrrolidines and tetrahydrofurans as novel AMPAR positive modulators 2010 ·Bioorganic & Medicinal Chemistry Letters ·Kevin M. Thewlis,Laura Aldegheri,Mark H Harries,Claudette Mookherjee,Beatrice Oliosi,Simon E. Ward	9
2	Integration of Lead Optimization with Crystallography for a Membrane-Bound Ion Channel Target: Discovery of a New Class of AMPA Receptor Positive Allosteric Modulators 2010 ·Journal of Medicinal Chemistry ·Simon E. Ward,Mark H Harries,Laura Aldegheri,Nigel Austin,Stuart P. Ballantine,(unknown),(unknown),B.D. Bax,Brian Clarke,A. I. Harris,Stephen A. Harrison,(unknown),Claudette Mookherjee,J. Mosley,Gianni Dal Negro,Beatrice Oliosi,Kathrine J. Smith,Kevin M. Thewlis,P.M. Woollard,Shahnaz P. Yusaf	57
3	Studies on a series of potent, orally bioavailable, 5-HT1 receptor ligands—Part II 2008 ·Bioorganic & Medicinal Chemistry Letters ·Simon E. Ward,Peter Eddershaw,(unknown),Laurie Gordon,Peter J. Lovell,(unknown),Claire M. Scott,Paul W. Smith,Kevin M. Thewlis,Paul Wyman	7
4	Discovery of Potent, Orally Bioavailable, Selective 5-HT_1A/B/D Receptor Antagonists 2008 ·Journal of Medicinal Chemistry ·Simon E. Ward,Peter Eddershaw,Claire M. Scott,Laurie Gordon,Peter J. Lovell,(unknown),Paul W. Smith,Kathryn R. Starr,Kevin M. Thewlis,Jeannette M. Watson	9
5	Studies on a series of potent, orally bioavailable, 5-HT1 receptor ligands 2007 ·Bioorganic & Medicinal Chemistry Letters ·Simon E. Ward,(unknown),Peter J. Lovell,Claire M. Scott,Paul W. Smith,Geoffrey Stemp,Kevin M. Thewlis,Antonio Vong,Jeannette M. Watson	6
6	SAR of biphenyl carboxamide ligands of the human melanin-concentrating hormone receptor 1 (MCH R1): Discovery of antagonist SB-568849 2006 ·Bioorganic & Medicinal Chemistry Letters ·David R. Witty,John H. Bateson,Guillaume Hervieu,Philip D. Jeffrey,Christopher N. Johnson,Alison I. Muir,Peter J. O’Hanlon,Geoffrey Stemp,(unknown),Kevin M. Thewlis,Shelagh Wilson,Kim Winborn	12
7	3,4-Dihydro-2H-benzoxazinones as dual-acting 5-HT1A receptor antagonists and serotonin reuptake inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Peter J. Lovell,Frank E. Blaney,(unknown),Claire M. Scott,Paul W. Smith,Kathryn R. Starr,Kevin M. Thewlis,Antonio Vong,Simon E. Ward,Jeannette M. Watson	13
8	Discovery of potent and stable conformationally constrained analogues of the MCH R1 antagonist SB-568849 2006 ·Bioorganic & Medicinal Chemistry Letters ·David R. Witty,John H. Bateson,Guillaume Hervieu,Kamal Albarazanji,Philip D. Jeffrey,Dieter Hamprecht,Andrea Haynes,Christopher N. Johnson,Alison I. Muir,Peter J. O’Hanlon,Geoffrey Stemp,(unknown),Kevin M. Thewlis,Kim Winborn	18
9	Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey:in vitro/in vivocorrelation and the role of aldehyde oxidase 2001 ·Xenobiotica ·Nigel Austin,(unknown),Leanne Cutler,Nigel Deeks,(unknown),(unknown),(unknown),Geoffrey Stemp,Kevin M. Thewlis,(unknown),Philip D. Jeffrey	52
10	Design and synthesis of novel 2,3-dihydro-1H-isoindoles with high affinity and selectivity for the dopamine D3 receptor 2001 ·Bioorganic & Medicinal Chemistry Letters ·Nigel Austin,Kim Y. Avenell,Izzy Boyfield,Clive L. Branch,Michael S. Hadley,Philip D. Jeffrey,Christopher N. Johnson,Gregor J. Macdonald,(unknown),Graham J. Riley,Alexander B. Smith,Geoffrey Stemp,Kevin M. Thewlis,Antonio Vong,Martyn Wood	13
11	Novel 2,3,4,5-tetrahydro-1H-3-benzazepines with high affinity and selectivity for the dopamine D3 receptor 2000 ·Bioorganic & Medicinal Chemistry Letters ·Nigel Austin,Kim Y. Avenell,Izzy Boyfield,Clive L. Branch,Michael S. Hadley,Philip D. Jeffrey,Christopher N. Johnson,Gregor J. Macdonald,David J. Nash,Graham J. Riley,Alexander B. Smith,Geoffrey Stemp,Kevin M. Thewlis,Antonio Vong,Martyn Wood	15
12	Design and Synthesis of trans-N-[4-[2-(6-Cyano-1,2,3,4-tetrahydroisoquinolin-2- yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A Potent and Selective Dopamine D₃ Receptor Antagonist with High Oral Bioavailability and CNS Penetration in the Rat 2000 ·Journal of Medicinal Chemistry ·Geoffrey Stemp,Tracey Ashmeade,Clive L. Branch,Michael S. Hadley,A. Jacqueline Hunter,Christopher N. Johnson,(unknown),Kevin M. Thewlis,Antonio Vong,Nigel Austin,Philip D. Jeffrey,Kim Y. Avenell,Izzy Boyfield,Jim J. Hagan,Derek N. Middlemiss,Charlie Reavill,Graham J. Riley,(unknown),Martyn Wood	110
13	Model studies on a synthetically facile series of N-substituted phenyl-N′-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT2C/2B receptor antagonists 1999 ·Bioorganic & Medicinal Chemistry ·Steven M. Bromidge,Steven Dabbs,David T. Davies,Susannah Davies,D. Malcolm Duckworth,Ian T. Forbes,(unknown),P. J. Ham,Graham E. Jones,(unknown),(unknown),Kevin M. Thewlis,Dolatrai M. Vyas,Thomas P. Blackburn,Vicky Holland,G.A. Kennett,Graham J. Riley,Martyn Wood	5
14	Novel 1,2,3,4-tetrahydroisoquinolines with high affinity and selectivity for the dopamine D3 receptor 1999 ·Bioorganic & Medicinal Chemistry Letters ·Nigel Austin,Kim Y. Avenell,Izzy Boyfield,Clive L. Branch,Martyn C. Coldwell,Michael S. Hadley,Philip D. Jeffrey,(unknown),Christopher N. Johnson,(unknown),Graham J. Riley,(unknown),(unknown),Geoffrey Stemp,Kevin M. Thewlis,Antonio Vong	15
15	Fused aminotetralins: novel antagonists with high selectivity for the dopamine D3 receptor 1998 ·Bioorganic & Medicinal Chemistry Letters ·Kim Y. Avenell,Izzy Boyfield,Martyn C. Coldwell,Michael S. Hadley,(unknown),(unknown),Christopher N. Johnson,(unknown),Graham J. Riley,(unknown),Stephen A. Smith,(unknown),Geoffrey Stemp,Kevin M. Thewlis	6
16	Novel and Selective 5-HT_2C/2B Receptor Antagonists as Potential Anxiolytic Agents: Synthesis, Quantitative Structure−Activity Relationships, and Molecular Modeling of Substituted 1-(3-Pyridylcarbamoyl)indolines 1998 ·Journal of Medicinal Chemistry ·Steven M. Bromidge,Steven Dabbs,David T. Davies,D. Malcolm Duckworth,Ian T. Forbes,P. J. Ham,Graham E. Jones,Frank D. King,(unknown),(unknown),Kevin M. Thewlis,Paul Wyman,Frank E. Blaney,Christopher Naylor,Fiona P. Bailey,Thomas P. Blackburn,Vicky Holland,G.A. Kennett,Graham J. Riley,Martyn Wood	53
17	6-Chloro-5-methyl-1-[[2-[(2-methyl-3- pyridyl)oxy]-5-pyridyl]carbamoyl]indoline (SB-242084): The First Selective and Brain Penetrant 5-HT_2C Receptor Antagonist 1997 ·Journal of Medicinal Chemistry ·Steven M. Bromidge,Malcolm Duckworth,Ian T. Forbes,P. J. Ham,Frank D. King,Kevin M. Thewlis,Frank E. Blaney,Christopher Naylor,Thomas P. Blackburn,G.A. Kennett,Martyn Wood,Stephen E. Clarke	72
18	A novel series of 2-aminotetralins with high affinity and selectivity for the dopamine D3 receptor 1997 ·Bioorganic & Medicinal Chemistry Letters ·Izzy Boyfield,Martyn C. Coldwell,Michael S. Hadley,Christopher N. Johnson,Graham J. Riley,(unknown),(unknown),Geoffrey Stemp,Kevin M. Thewlis	13

About Kevin M. Thewlis

Kevin M. Thewlis is a scholar working on Cellular and Molecular Neuroscience, Endocrine and Autonomic Systems and Pharmacology, having authored 18 papers that have together received 485 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (13 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Pharmacological Receptor Mechanisms and Effects (6 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (259 citations), Molecular Biology (315 citations) and Pharmaceutical Science (27 citations). Kevin M. Thewlis has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Geoffrey Stemp, Martyn Wood, Philip D. Jeffrey, Nigel Austin, Graham J. Riley, Antonio Vong, Michael S. Hadley, Frank E. Blaney, Izzy Boyfield and Christopher N. Johnson. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact